Document is current

Article History

Received: 6 March 2023

Accepted: 22 May 2023

First Online: 1 June 2023

Declarations

:

: This study was performed in line with the principles of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was performed at University Hospitals Leuven in collaboration with University Hospital Antwerp and University Hospital Ghent after approval by the Ethics Committee of all three institutes (ClinicalTrials.gov identifier NCT04552847). Written informed consent was obtained from all individual participants included in the study.

: The authors affirm that human research participants provided informed consent for the publication of the images in Figs. InternalRef removed, InternalRef removed, InternalRef removed, and InternalRef removed.

: Paul M. Clement received study budget funds from AstraZeneca and was an advisory board member for AbbVie, AstraZeneca, Bayer, BMS, Daiichi-Sankyo, Leo Pharma, Merck Serono, MSD, Rakuten, Takeda, and Vifor Pharma, outside the scope of the submitted work. Christophe M. Deroose has been a consultant for Terumo, Ipsen, Sirtex, Bayer, and PSI CRO outside the scope of the submitted work. There are no other conflicts of interest.